Logo image of QNTM

QUANTUM BIOPHARMA LTD (QNTM) Stock Price, Quote, News and Overview

NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD

22.64  +0.78 (+3.57%)

After market: 22.6 -0.04 (-0.18%)

QNTM Quote, Performance and Key Statistics

QUANTUM BIOPHARMA LTD

NASDAQ:QNTM (7/23/2025, 8:00:00 PM)

After market: 22.6 -0.04 (-0.18%)

22.64

+0.78 (+3.57%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap66.34M
Shares2.93M
Float2.57M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12
IPO05-29 2018-05-29


QNTM short term performance overview.The bars show the price performance of QNTM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 200 400

QNTM long term performance overview.The bars show the price performance of QNTM in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of QNTM is 22.64 USD. In the past month the price decreased by -16.55%.

QUANTUM BIOPHARMA LTD / QNTM Daily stock chart

QNTM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 58.06 757.14B
JNJ JOHNSON & JOHNSON 16.91 406.87B
NVO NOVO-NORDISK A/S-SPONS ADR 19.03 311.17B
NVS NOVARTIS AG-SPONSORED ADR 13.33 228.37B
AZN ASTRAZENECA PLC-SPONS ADR 16.78 226.33B
MRK MERCK & CO. INC. 10.78 210.88B
PFE PFIZER INC 7.9 144.18B
SNY SANOFI-ADR 11 122.14B
BMY BRISTOL-MYERS SQUIBB CO 6.67 99.68B
GSK GSK PLC-SPON ADR 8.55 76.94B
ZTS ZOETIS INC 25.49 68.32B
TAK TAKEDA PHARMACEUTIC-SP ADR 64.09 46.04B

About QNTM

Company Profile

QNTM logo image Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Company Info

QUANTUM BIOPHARMA LTD

55 University Ave. , Suite 1003

TORONTO ONTARIO CA

Employees: 10

QNTM Company Website

QNTM Investor Relations

Phone: 14168548884

QUANTUM BIOPHARMA LTD / QNTM FAQ

What is the stock price of QUANTUM BIOPHARMA LTD today?

The current stock price of QNTM is 22.64 USD. The price increased by 3.57% in the last trading session.


What is the ticker symbol for QUANTUM BIOPHARMA LTD stock?

The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.


On which exchange is QNTM stock listed?

QNTM stock is listed on the Nasdaq exchange.


What is QUANTUM BIOPHARMA LTD worth?

QUANTUM BIOPHARMA LTD (QNTM) has a market capitalization of 66.34M USD. This makes QNTM a Micro Cap stock.


How many employees does QUANTUM BIOPHARMA LTD have?

QUANTUM BIOPHARMA LTD (QNTM) currently has 10 employees.


What are the support and resistance levels for QUANTUM BIOPHARMA LTD (QNTM) stock?

QUANTUM BIOPHARMA LTD (QNTM) has a support level at 21.86 and a resistance level at 23.37. Check the full technical report for a detailed analysis of QNTM support and resistance levels.


Should I buy QUANTUM BIOPHARMA LTD (QNTM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUANTUM BIOPHARMA LTD (QNTM) stock pay dividends?

QNTM does not pay a dividend.


When does QUANTUM BIOPHARMA LTD (QNTM) report earnings?

QUANTUM BIOPHARMA LTD (QNTM) will report earnings on 2025-08-12.


What is the Short Interest ratio of QUANTUM BIOPHARMA LTD (QNTM) stock?

The outstanding short interest for QUANTUM BIOPHARMA LTD (QNTM) is 5.46% of its float. Check the ownership tab for more information on the QNTM short interest.


QNTM Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to QNTM.


Chartmill TA Rating
Chartmill Setup Rating

QNTM Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

QNTM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners2.67%
Ins Owners8.89%
Short Float %5.46%
Short Ratio0.48
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A